Navigation Links
The cortex plays an essential part in emotional learning

The study, initiated by the Swiss researchers and published in Nature, constitutes ground-breaking work in exploring emotions in the brain.

Anxiety disorders constitute a complex family of pathologies affecting about 10% of adults. Patients suffering from such disorders fear certain situations or objects to exaggerated extents totally out of proportion to the real danger they present. The amygdala, a deep-brain structure, plays a key part in processing fear and anxiety. Its functioning can be disrupted by anxiety disorders.

Although researchers are well acquainted with the neurons of the amygdala and with the part those neurons play in expressing fear, their knowledge of the involvement of other regions of the brain remains limited. And yet, there can be no fear without sensory stimulation: before we become afraid, we hear, we see, we smell, we taste, or we feel something that triggers the fear. This sensory signal is, in particular, processed in the cortex, the largest region of the brain.

For the first time, these French and Swiss scientists have succeeded in visualising the path of a sensory stimulus in the brain during fear learning, and in identifying the underlying neuronal circuits.

What happens in the brain?

During the experiments conducted by the researchers, mice learnt to associate a sound with an unpleasant stimulus so that the sound itself became unpleasant for the animal.

The researchers used two-photon calcium imaging to visualise the activity of the neurons in the brain during this learning process. This imaging technique involves injecting a chemical indicator that is then absorbed by the neurons. When the neurons are stimulated, the calcium ions penetrate into the cells, where they increase the brightness of the indicator, which can then be detected under a scanning microscope.

Under normal conditions, the neurons of the auditory cortex are highly inhibited. During fear learning, a "disinhibitory" microcircuit in the cortex is activated: thus, for a short time window during the learning process, the release of acetylcholine in the cortex makes it possible to activate this microcircuit and to disinhibit the excitatory projection cells of the cortex. Thus, when the animal perceives a sound during fear learning, that sound is processed much more intensely than under normal conditions, thereby facilitating formation of memory. All of these stages have been visualised by means of the techniques developed by the researchers.

In order to confirm their discoveries, the researchers used another highly innovative recent technique (optogenetics) to disrupt the disinhibition selectively during the learning process. When they tested the memories of their mice (i.e. the association between the sound and the unpleasant stimulus), the next day they observed a severe deterioration in memory, directly showing that the phenomenon of cortical disinhibition is essential to the process of learning fear.

The discovery of this cortical disinhibitory microcircuit opens up interesting clinical prospects, and researchers can now imagine, in very specific situations, how to prevent a traumatism from establishing itself and from becoming pathological.

Contact: Inserm Presse
INSERM (Institut national de la sant et de la recherche mdicale)

Related medicine news :

1. Frontal cortex dysfunction may contribute to compulsive sexual behavior
2. Metabolic protein plays unexpected role in tumor cell formation and growth
3. Where Folks Live Plays Role in Health Disparities: Study
4. Ancestry plays vital role in nutrition and disease, study shows
5. Unemployment Plays Role in Early Deaths, Research Shows
6. New fusion gene plays role in some stomach cancers
7. UCLA study finds cholesterol regulator plays key role in development of liver scarring, cirrhosis
8. Researchers find brain insulin plays critical role in the development of diabetes
9. Parents Have Stronger Relationship When Dad Plays With Kids
10. For non-whites, geography plays key role in colon cancer screening
11. Protein involved in cystic fibrosis also plays role in emphysema, chronic lung disease
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, I ... Bronx, N.Y. “I thought there had to be a convenient and comfortable way to ... The PROTECTOR enables disabled individuals to safely travel during cold or inclement weather. In ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... philanthropic seniors, is resulting in a way for homeless people to have a ... have launched a new initiative whereby they are repurposing plastic bags into sleeping ...
(Date:11/25/2015)... ... November 25, 2015 , ... Since its launch in 2012, ... adult stem cell therapies to patients with chronic degenerative medical conditions. Now, the ... Registered Trademark (RTM). , Organizations are required to hold a registered trademark in ...
(Date:11/24/2015)... ... November 25, 2015 , ... Genesis Chiropractic Software ... software creates an agreement between the practice owner and the patient that automatically ... notification, and projections. Click here to learn more. , ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... FRANCISCO , Nov. 24, 2015  Thanks to ... Dignity Health St. Mary,s Medical Center,s Sister Diane Grassilli ... breast imaging capabilities in San Francisco ... an anonymous friend, stepped forward with a gift of ... for Breast Digital Mammography with Tomosynthesis and Whole Breast ...
(Date:11/24/2015)... Colo. , Nov. 24, 2015  Array ... that its Chief Executive Officer, Ron Squarer ... Healthcare Conference in New York.  The public is ... webcast on the Array BioPharma website.Event:Piper Jaffray Annual ... , Wednesday, December 2, 2015Time:1:30 p.m. Eastern Time ...
(Date:11/24/2015)... HOUSTON, TX and VANCOUVER, Nov. 24, 2015 /PRNewswire/ ... EPI; NASDAQ: EPIX ) announced today that the ... clinical study of EPI-506 as a treatment for metastatic ... States and Canada.  --> ... --> In the Phase 1/2 clinical trial, ...
Breaking Medicine Technology: